Search results for "Prom"

showing 10 items of 2286 documents

Slit-Robo Pathway Is Clinically Relevant and May Represent a Potential Target in Acute Promyelocytic Leukemia

2018

Abstract Background: The Slit-Robo pathway has been shown to participate in the pathogenesis of several malignant diseases in addition to its physiologic role during the development of the central nervous system (CNS). However, the relevance of the Slit-Robo pathway in acute promyelocytic leukemia (APL) is presently unknown. We investigated the status of the Slit-Robo pathway in APL following the recent demonstration by Amodeo et al (CellRep. 2017) that the PML protein induces neural stem/progenitor cells migration by inhibiting the SLIT2 gene, which was associated with an increased presence of H3K27me3 in the SLIT2 promotor region. Moreover, sensitivity towards the PML-targeting drug arsen…

Acute promyelocytic leukemiaPrimary Glioblastomamedicine.medical_specialtyAcute leukemiaProliferation indexbusiness.industryImmunologyHealthy subjectsCell BiologyHematologymedicine.diseaseSlit2 proteinBiochemistryColony formationFamily medicinemedicinebusinessCell survivalBlood
researchProduct

Clinical and Functional Studies Reveal That TP73 Isoforms Levels Are Associated with Prognosis and RA-Resistance in Acute Promyelocytic Leukemia

2019

Background: TP73 isoforms gained particular relevance in acute promyelocytic leukemia (APL) since Bernasola et al (JEM. 2004) demonstrated that TAp73 was directly regulated by the PML protein in the nuclear body. The isoforms differ in their transcriptional activity, with those lacking domains in the N-terminal part of the protein exerting a dominant negative effect on TP73 function. In a retrospective analysis of patients with APL treated in ICAPL study, Lucena-Araujo et al (Blood 2015) demonstrated the association between higher ΔNp73/TAp73 ratio values and poor clinical outcome. However,there is a diversity of TP73 isoforms and specially those lacking N-terminal domains (e.g.ΔEx2p73, ΔEx…

Acute promyelocytic leukemiaTranscriptional activitymedicine.medical_specialtySupervisory boardbusiness.industryeducationImmunologyDisease progressionCell BiologyHematologyNewly diagnosedmedicine.diseaseBiochemistryFamily medicinemedicineFunctional studiesProtein abundancebusinessHematology+Oncologyhealth care economics and organizationsBlood
researchProduct

Towards More Specificity and Effectivity in the Antileukemia Immune Response

2014

Experimental and clinical studies have shown that alloreactive T-cell responses derived from donor lymphocytes can effectively eliminate leukemia cells after allogeneic hematopoietic stem cell transplantation. However, there are still too many patients in whom this graft-versus-leukemia reactivity is insufficient to prevent leukemia relapse or who suffer from severe alloreactivity to nonmalignant host tissues also mediated by donor-derived T cells. Therefore, various conceptually different approaches have been developed at the level of donor T cells in order to improve the efficacy of leukemia-directed immunity while reducing the incidence of unwanted graft-versus-host disease. As outlined …

Acute promyelocytic leukemiabusiness.industrymedicine.medical_treatmentMyeloid leukemiaHematopoietic stem cell transplantationmedicine.diseaseDonor LymphocytesMinimal residual diseaseTransplantationLeukemiaImmune systemImmunologyMedicinebusiness
researchProduct

Arsenic Trioxide Abrogate MN1 Mediated RA-Resistance in Acute Promyelocytic Leukemia

2019

Introduction: Described as a well know marker of worse prognosis in acute myeloid leukemia (AML), MN1 overexpression has been associated with inv(16) or EVI1 overexpression (Heuser et al., Blood 2007). The promoter region of the MN1 gene has Retinoic Acid Response Elements (RAREs), and higher levels of MN1 expression have been associated with decreased response to retinoic acid (RA) in vitro. Nevertheless, in the context of acute promyelocytic leukemia, little is known about MN1 gene expression and functionality in vivo. Aims: Here, we investigated the effects of in vitro treatment with RA plus arsenic trioxide (ATO) in APL cell lines and primary blasts overexpressing MN1. Additionally, we …

Acute promyelocytic leukemiaeducationImmunologyCancerCell BiologyHematologyHematologic Neoplasmsmedicine.diseaseBiochemistryLeukemiachemistry.chemical_compoundchemistryTretinoinCell cultureMacrophage-1 antigenCancer researchmedicineArsenic trioxidehealth care economics and organizationsmedicine.drugBlood
researchProduct

Treatment Results In Acute Myeloid Leukemia Over a Time Period Of 20 Years: Analysis Of The German-Austrian Acute Myeloid Leukemia Study Group (AMLSG)

2013

Abstract Background Overall survival (OS) in acute myeloid leukemia (AML) treated with intensive chemotherapy has improved over the last 20 year especially in younger adults (18-60 years) but still remains poor in older patients (>60 years) (Döhner et al. Blood 2010). The German-Austrian AMLSG performed controlled prospective treatment trials since 1993 starting with a risk-adapted approach (phase I, 1993-1997), followed by randomized and risk-adapted treatment strategies based on cytogenetic risk groups (phase II, 1997-2002); since 2003 addition of differentiating agents and HiDAC inhibitors to intensive induction therapy was evaluated (phase III, 2003-2007). Of note, until 2007 younger…

Acute promyelocytic leukemiamedicine.medical_specialtyPediatricsmedicine.medical_treatmentImmunologyHematopoietic stem cell transplantationBiochemistry03 medical and health sciences0302 clinical medicineInternal medicinemedicineMyelofibrosisNeoadjuvant therapy030304 developmental biology0303 health sciencesChemotherapybusiness.industryMortality rateCell BiologyHematologymedicine.diseasePomalidomideChemotherapy regimen3. Good healthbusiness030215 immunologymedicine.drugBlood
researchProduct

Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet

2019

Abstract Since the comprehensive recommendations for the management of acute promyelocytic leukemia (APL) reported in 2009, several studies have provided important insights, particularly regarding the role of arsenic trioxide (ATO) in frontline therapy. Ten years later, a European LeukemiaNet expert panel has reviewed the recent advances in the management of APL in both frontline and relapse settings in order to develop updated evidence- and expert opinion–based recommendations on the management of this disease. Together with providing current indications on genetic diagnosis, modern risk-adapted frontline therapy, and salvage treatment, the review contains specific recommendations for the …

Acute promyelocytic leukemiamedicine.medical_specialtymedicine.medical_treatmentImmunologyMEDLINETretinoinDiseaseHemorrhagic DisordersBiochemistryHemorrhagic disorderEuropean LeukemiaNetArsenic TrioxideLeukemia Promyelocytic AcutePregnancyRecurrenceHumansMedicineDisease management (health)Intensive care medicineSpecial ReportNeoadjuvant therapyAPL Differentiation SyndromeAgedbusiness.industryDisease ManagementCell BiologyHematologymedicine.diseasePractice Guidelines as TopicFemalebusinessBlood
researchProduct

Genome-wide characterization of chromatin binding and nucleosome spacing activity of the nucleosome remodelling ATPase ISWI.

2010

The evolutionarily conserved ATP-dependent nucleosome remodelling factor ISWI can space nucleosomes affecting a variety of nuclear processes. In Drosophila, loss of ISWI leads to global transcriptional defects and to dramatic alterations in higher-order chromatin structure, especially on the male X chromosome. In order to understand if chromatin condensation and gene expression defects, observed in ISWI mutants, are directly correlated with ISWI nucleosome spacing activity, we conducted a genome-wide survey of ISWI binding and nucleosome positioning in wild-type and ISWI mutant chromatin. Our analysis revealed that ISWI binds both genic and intergenic regions. Remarkably, we found that ISWI…

Adenosine TriphosphatasesMaleChromatin ImmunoprecipitationX ChromosomeD. melanogasterSettore INF/01 - Informaticachromatin remodellingGenomicsChromatin Assembly and DisassemblyArticleNucleosomesDNA-Binding ProteinsISWInucleosome spacingGene Expression RegulationSettore BIO/10 - BiochimicaAnimalsDrosophila ProteinsDrosophilaPromoter Regions GeneticCrosses GeneticProtein BindingTranscription FactorsThe EMBO journal
researchProduct

Green composites: A brief review

2011

The rising concern towards environmental issues and, on the other hand, the need for more versatile polymer-based materials has led to increasing interest about polymer composites filled with natural-organic fillers, i.e. fillers coming from renewable sources and biodegradable. The composites, usually referred to as "green", can find several industrial applications. On the other hand, some problems exist, such as worse processability and reduction of the ductility. The use of adhesion promoters, additives or chemical modification of the filler can help in overcoming many of these limitations. These composites can be further environment-friendly when the polymer matrix is biodegradable and c…

Adhesion promotersA. Polymer-matrix composites (PMCs)Materials scienceB. Mechanical propertieMechanics of MaterialsFiller (materials)A. WoodCeramics and CompositesengineeringPolymer compositesCeramics and Compositeengineering.materialComposite material
researchProduct

Oral health of cystic fibrosis patients at a north american center: A pilot study

2019

Background The objective of this study was to describe the oral health status of Cystic Fibrosis (CF) children in a US facility. Material and Methods Twenty CF children ages 6-18 were recruited from Children’s Hospital of Wisconsin Pulmonary Clinic. Parents completed a health questionnaire. Clinical examinations checked dental caries using the dmft/DMFT index, dental hygiene using the Simplified Greene-Vermillion Index (DI-S), gingival inflammation using the Community Periodontal Index of Treatment Needs, and enamel defects using the modified Developmental Defects of Enamel Index. Results The majority (90%) brush twice a day, 65% consume sugary snacks, and 70% visit the dentist every 6 mont…

AdolescentCystic FibrosisEnamel defectsDentistryOral HealthPilot ProjectsDental CariesOral healthOral hygieneCystic fibrosis03 medical and health sciences0302 clinical medicinestomatognathic systemPrevalencemedicineHumansChildGeneral DentistryEnamel paintDMF Indexbusiness.industryResearchDMFT Index030206 dentistryDental hygiene:CIENCIAS MÉDICAS [UNESCO]Medically compromised patients in DentistryOral Hygienemedicine.diseaseUnited Statesstomatognathic diseasesOtorhinolaryngologyvisual_artUNESCO::CIENCIAS MÉDICASvisual_art.visual_art_mediumSurgeryMild gingivitisbusinessMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Young People in the Social World of Physical Activities : Meanings and Barriers

2022

Physical inactivity has become one of the leading risk factors for non-communicable diseases (NCDs) and death worldwide. From the future perspective it is alarming that in the group of young people few meet the recommendations. In this respect, physical activity promotion in general and physical education have challenges and new approaches are needed. In this study, the theoretical framework is based on the physical activity relationship (PAR) approach and the barriers were grouped according to the ecological model. The aim of the study was firstly to present both the meanings and barriers of physical activity in a comprehensive Finnish population of 11–15 year old (n = 2728) and secondly t…

AdolescentHealth Toxicology and MutagenesisPublic Health Environmental and Occupational Healthphysical activityliikkumattomuusliikuntaesteetliikuntakasvatusfyysinen kuntophysical activity; adolescent; physical activity promotion; physical educationphysical educationnuoretSurveys and QuestionnairesadolescentHumansSedentary Behaviorphysical activity promotionmerkitys (tärkeys)ChildNoncommunicable DiseasesExerciseFinlandfyysinen aktiivisuus
researchProduct